1. Home
  2. RCMT vs NYXH Comparison

RCMT vs NYXH Comparison

Compare RCMT & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RCM Technologies Inc.

RCMT

RCM Technologies Inc.

HOLD

Current Price

$27.50

Market Cap

140.8M

ML Signal

HOLD

Logo Nyxoah SA

NYXH

Nyxoah SA

HOLD

Current Price

$3.11

Market Cap

152.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RCMT
NYXH
Founded
1971
2009
Country
United States
Belgium
Employees
N/A
N/A
Industry
Professional Services
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
140.8M
152.8M
IPO Year
1997
2021

Fundamental Metrics

Financial Performance
Metric
RCMT
NYXH
Price
$27.50
$3.11
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$11.25
AVG Volume (30 Days)
60.1K
56.6K
Earning Date
04-03-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
27.38
N/A
EPS
2.14
N/A
Revenue
$186,737,000.00
N/A
Revenue This Year
$16.29
$214.32
Revenue Next Year
$6.92
$124.13
P/E Ratio
$12.73
N/A
Revenue Growth
5.83
N/A
52 Week Low
$15.29
$2.76
52 Week High
$28.19
$8.64

Technical Indicators

Market Signals
Indicator
RCMT
NYXH
Relative Strength Index (RSI) 82.25 44.47
Support Level $26.23 $2.76
Resistance Level N/A $3.32
Average True Range (ATR) 1.34 0.18
MACD 0.98 0.08
Stochastic Oscillator 96.68 53.41

Price Performance

Historical Comparison
RCMT
NYXH

About RCMT RCM Technologies Inc.

RCM Technologies Inc is a provider of business and technology solutions designed to enhance and maximize the operational performance of its customers. It operates in three segments: Specialty Health Care, Engineering, and Life Sciences, Data and Solutions (LS&D). The company generates maximum revenue from the Specialty Health Care segment that provides staffing solutions including medical healthcare professionals, health information management professionals, nurses, paraprofessionals, physicians, and therapists. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Puerto Rico, the Philippines, and Europe.

About NYXH Nyxoah SA

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

Share on Social Networks: